Allworth Financial’s Definium Therapeutics DFTX Stock Holding History

Allworth Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.4K	Sell	127 -21	-14%	-$356	﹤0.01%	4290
2025 Q4	$1.98K	Buy	148 +63	+74%	+$780	﹤0.01%	4127
2025 Q3	$1K	Hold	85	–	–	﹤0.01%	4250
2025 Q2	$552	Buy	85 +16	+23%	+$105	﹤0.01%	4113
2025 Q1	$444	Hold	69	–	–	﹤0.01%	3713
2024 Q4	$484	Buy	69 +3	+5%	+$21	﹤0.01%	3611
2024 Q3	$376	Hold	66	–	–	﹤0.01%	3480
2024 Q2	$524	Hold	66	–	–	﹤0.01%	3356
2024 Q1	$621	Hold	66	–	–	﹤0.01%	3225
2023 Q4	$242	Hold	66	–	–	﹤0.01%	3266
2023 Q3	$207	Hold	66	–	–	﹤0.01%	3225
2023 Q2	$236	Hold	66	–	–	﹤0.01%	3066
2023 Q1	$210	Hold	66	–	–	﹤0.01%	3000
2022 Q4	$145	Sell	66 -16	-20%	-$44	﹤0.01%	2868
2022 Q3	$0	Buy	82 +15	+22%	+$144	﹤0.01%	2930
2022 Q2	$1K	Hold	67	–	–	﹤0.01%	2199
2022 Q1	$1K	Buy	+67	New	+$1.16K	﹤0.01%	1971

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allworth Financial's DFTX Position: Q1 2026 in Review

Allworth Financial reduced its Definium Therapeutics (DFTX) stake by 14% in Q1 2026, selling an estimated $356 and leaving 127 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Allworth Financial first reported a position in DFTX in Q1 2022 and has held it in 17 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Allworth Financial held 127 shares of Definium Therapeutics worth $2.4K as of Q1 2026.
Allworth Financial sold 21 Definium Therapeutics shares in Q1 2026, an estimated $356.
Definium Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4290 holding.
Allworth Financial first reported a position in Definium Therapeutics in Q1 2022 and has held it in 17 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.